Independent Biotechnology Companies
- The following is a list of the top 25 independent biotechnology companies listed on a stock exchange ranked by Market Capitalization in Q2 of 2012. It additionally details their market capitalization in Q2 of the previous year (2011), from which the change in value over the year can be calculated.
- Note that it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups - such as Genentech (owned by Roche), Genzyme (Sanofi), or MedImmune (AstraZeneca). It should be viewed as an update and complementary to the previous table below.
| Rank 2012 | Company | Country | Market Cap in 2012 | Market Cap in 2011 | % Change over year (Q2-Q2) | Website |
|---|---|---|---|---|---|---|
| 1 | Novo Nordisk | Denmark | 76.92 | 60.09 | 28.0% | novonordisk.com |
| 2 | Amgen | USA | 60.09 | 49.72 | 20.9% | amgen.com |
| 3 | Gilead Sciences | USA | 40.16 | 32.68 | 28.5% | gilead.com |
| 4 | Biogen Idec | USA | 34.26 | 25.6 | 28.5% | biogenidec.com |
| 5 | Teva Pharmaceutical Industries | Israel | 34.23 | 42.96 | -20.3% | tevapharm.com |
| 6 | Baxter International | USA | 32.27 | 33.36 | -3.3% | baxter.com |
| 7 | Celgene | USA | 28.38 | 27.52 | 3.1% | celgene.com |
| 8 | Merck KGaA | Germany | 21.16 | 20.14 | 5.1% | merckgroup.com |
| 9 | CSL | Australia | 21.11 | 18.33 | 15.2% | csl.com.au |
| 10 | Alexion Pharmaceuticals | USA | 18.85 | 10.48 | 79.9% | alxn.com |
| 11 | Vertex Pharmaceuticals | USA | 10.64 | 10.79 | -1.4% | vrtx.com |
| 12 | Regeneron | USA | 11.3 | 5.09 | 122.0% | regeneron.com |
| 13 | Forest Laboratories | USA | 8.87 | 9.09 | -2.4% | frx.com |
| 14 | UCB | Belgium | 8.77 | 6.84 | 28.2% | ucb.com |
| 15 | Élan | Ireland | 8.63 | 6.67 | 29.4% | elan.com |
| 16 | BioMarin Pharmaceutical | USA | 5.35 | 3.32 | 61.1% | biomarinpharm.com |
| 17 | Dr. Reddy's Laboratories | India | 5.35 | 5.03 | 6.4% | drreddys.com |
| 18 | Amylin Pharmaceuticals § | USA | 5.06 | 1.74 | 190.8% | amylin.com |
| 19 | Onyx Pharmaceuticals | USA | 5.06 | 2.1 | 141.0% | onyx.com |
| 20 | Actelion | Switzerland | 4.65 | 5.02 | -7.4% | actelion.com |
| 21 | Warner Chilcott | Ireland | 4.49 | 5.69 | -21.1% | wcrx.com |
| 22 | Ranbaxy Laboratories | India | 3.71 | 4.08 | -9.1% | ranbaxy.com |
| 23 | Medivation | USA | 3.65 | 0.683 | 433.4% | medivation.com |
| 24 | ARIAD Pharmaceuticals | USA | 3.18 | 1.58 | 101.3% | ariad.com |
| 25 | Seattle Genetics | USA | 2.92 | 1.89 | 54.5% | seagen.com |
§ - Acquired by Bristol-Myers Squibb in a $7 billion deal completed Aug 8 2012 (therefore no longer independent in this list going forward).
NOTE: Market Cap is an indication of the perceived value of the company (&/or its technology) and not necessarily a measure of its size, sales or number of employees; it is indicative of both current and future scale and profitability of the company. The year-on-year change in its value is indicative of the (real or perceived) performance or progress of that company over that year.
Read more about this topic: List Of Biotechnology Companies
Famous quotes containing the words independent and/or companies:
“Surrealism, n. Pure psychic automatism, by which it is intended to express, whether verbally or in writing, or in any other way, the real process of thought. Thought’s dictation, free from any control by the reason, independent of any aesthetic or moral preoccupation.”
—André Breton (1896–1966)
“In the U.S. for instance, the value of a homemaker’s productive work has been imputed mostly when she was maimed or killed and insurance companies and/or the courts had to calculate the amount to pay her family in damages. Even at that, the rates were mostly pink collar and the big number was attributed to the husband’s pain and suffering.”
—Gloria Steinem (20th century)